Ibrahim Moussa
Interventional Cardiology · Cherry Hill, NJNPI 1659382604
Payments from drug & device makers
Across 474 payments — averaging $178.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Surmodics, Inc.$31K
- Medtronic$17K
- Abbott$16K
- Angiodynamics, Inc.$9K
- Edwards Lifesciences$4K
- Shockwave Medical, Inc$2K
- plus $6K from 24 others
Across 1 payment — averaging $3800.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Medtronic$4K
What the payments were for
- Consulting fees$9633%
- Travel & lodging$19,42058%
- Food & beverage$12,99339%
- Education$220%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Surmodics, Inc. | 34 | $30,758 |
| Medtronic(2 entities) | 78 | $16,899 |
| Abbott | 66 | $16,393 |
| Angiodynamics, Inc. | 2 | $8,773 |
| Edwards Lifesciences | 38 | $3,502 |
| Shockwave Medical, Inc | 31 | $2,122 |
| Boston Scientific | 58 | $1,273 |
| Amgen | 52 | $752 |
| Abiomed | 12 | $636 |
| Inari Medical, Inc. | 5 | $612 |
| Penumbra, Inc. | 8 | $558 |
| Siemens Medical Solutions USA, Inc. | 4 | $485 |
| AstraZeneca | 18 | $241 |
| Stryker | 2 | $227 |
| Johnson & Johnson | 14 | $203 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 12 | $198 |
| W. L. Gore & Associates, Inc. | 5 | $183 |
| Pfizer | 9 | $138 |
| Cardiovascular Systems Inc. | 3 | $124 |
| Cashflow Solutions, LLC | 3 | $108 |
| E.r. Squibb & Sons, L.L.C. | 8 | $106 |
| Avinger Inc. | 1 | $100 |
| Cardinal Health 200 LLC | 3 | $54 |
| Bard Peripheral Vascular, Inc. | 2 | $45 |
| Terumo Medical Corporation | 1 | $18 |
| Cordis US CORP. | 1 | $17 |
| Biocompatibles, Inc. | 1 | $16 |
| Bardy Diagnostics, Inc. | 1 | $15 |
| Chiesi USA, Inc. | 1 | $15 |
| Tactile Systems Technology Inc | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- COREVALVE EVOLUT R$11,795
- MitraClip$1,657
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$963
- SurVeil$711
- FLOWTRIEVER CATHETER, S$480
- CT THROMBECTOMY SYSTEM KIT$480
- Indigo System$479
- Artis icono floor$360
- ARTIS icono biplane$360
- CoreValve Evolut$280
- ARTIX MT$227
- EVOQUE$196
- AMPLATZER Occluders$133
- GORE CARDIOFORM Septal Occluder$122
- GENERAL - STENTS$116
- Impella$114
- Edwards SAPIEN 3 Transcatheter Heart Valve$112
- SYNERGY$100
- PANTHERIS$100
- AVVIGO Guidance System$100
How this compares
$84,584 in reported general payments places this provider in the 85th percentile of 166 interventional cardiology providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 55 | $44,049 |
| Repatha SureclickEvolocumab | 11 | $12,086 |
| ClopidogrelClopidogrel Bisulfate | 73 | $1,559 |
| Rosuvastatin Calcium | 35 | $865 |
| Isosorbide Mononitrate ErIsosorbide Mononitrate | 41 | $414 |
| Cilostazol | 20 | $280 |
| Atorvastatin Calcium | 23 | $188 |
| Amlodipine Besylate | 11 | $166 |
| Losartan Potassium | 15 | $128 |
| Spironolactone | 23 | $81 |
| Metoprolol Tartrate | 28 | $77 |
| Furosemide | 30 | $75 |
| Digoxin | 15 | $68 |
| Amoxicillin | 13 | $29 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $138 | $44,04955 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 166 interventional cardiology providers in New Jersey.
Other interventional cardiology in Cherry Hill
- Luai TabazaCherry Hill$243K
- John FinleyCherry Hill$23K
- Dinesh SingalSomerset$1.4M
- Ankitkumar PatelGlen Ridge$717K
- Matthew SayboltEatontown$671K
- Jaffar RazaSecaucus$537K
- Kintur SanghviBordentown$467K
- Ziad AbbudOcean$361K
- Ramin HastingsHasbrouck Heights$355K
- Ryan KapleHackensack$280K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.